ESR1 and breast carcinoma: In breast cancer cells, ectopic overexpression of TTP was capable of repressing the transactivation activity of nuclear receptors, including estrogen receptor alpha (ERα), progesterone receptor (PR), glucocorticoid receptor (GR), and androgen receptor (AR), via physically interacting with these factors [128].